Drugs Only, Block 1 Pharm Flashcards
Pilocarpine
Cholinergic Agonist
IND:
EYE: Reduce IOP in ocular HTN, Prevent Post Op IOP
Oral: Xerostomia
ADE: DUMBELLS Decreased Far Visón
Bethanechol
Cholinergic Agonist
MOA: increases bladder contraction relaxes sphincter
IND: acute PostOP nonobstructive UOP retention, neurogenic stony of urinary bladder
ADE: DUMBBELLS
Contra: Obstruction, Asthma, PUD, Bradycardia
Edrophonium
Competive Indirect Cholinergic Agonist
MOA: Short acting that potentiates acetylcholine activity by inhibiting its destruction
IND: DDx of Myasthenia Gravis, Myasthenia Crisis, reverse the effects of non-depolarizing neuromuscular blocking agents (not succs)
ADE: DUMBBELLS
Contra: Obstruction of GU/GI, when the bladder wall strength is questionable
Physostigmine Salicylate
Indirect Cholinergic Agonist
MOA: competitive (reversible) acetylcholinesterase inhibitor that potentiates acetylcholine activity by inhibiting its destruction
IND: Reversal for OD on anticholinergics, reserved for severe life threatening cases (Extensive delirium or agitation, hallucination, hyperthermia, supraventricular tachycardia)
MAKE SURE TO MONITOR THE PT! ECG, VITALS.
ADE: SEVERE DUMBBELLS
Contra: Obstruction GI/GU, RR distress or SZR
Neostigmine
Indirect Cholinergic Agonist
MOA: Synthetic Competitive acetylcholinesterase inhibitor
Medium Acting
IND: Tx of Myasthenia Gravis, Reversal of no depolarizing blocking agents
(More polar than pheostigmine) (Less SZR)
Route: PO, IV
ADE: DUMBBELLS
Contra: Obstruction of GU/GI
CAUTION: Asthma, PUD, or Bradycardia
Pyridostigmine
Indirect cholinergic agonist
competitive (reversible) acetylcholinesterase inhibitor
Medium Acting
IND: Tx of myasthenia Gravis, reverse non depolarizing blocking agents, nerve agent pretreatment
ADE: DUMBBELLS
Contra: GI/GU obstruction, weak bladder wall
CAUTION: ASTHMA, PUD, Bradycardia
Echothiophate
Only noncompetitive acetylcholinesterase inhibitor used on a regular basis
MOA: indirect cholinergic agonist that contracts the ciliary muscle leading to increase aqueous humor outflow
IND: Gluacoma
ADE: Miosis, decreased accommodation (far vision)
Pralidoxime
MOA: Reactivate cholinesterase, detoxifies certain organophosphates, reverses the paralysis of respiratory muscles
IND: Anitdote for organophosphate OD and anti cholinesterase drugs
ADE: blurred vision, diplopia, impaired accommodation, dizziness, headache, drowsiness, nausea, tachycardia, increased systolic and diastolic blood pressure, hyperventilation, and muscular weakness when given parentally to normal people who have not been exposed to anticholinesterase poisons.
ATNAA
Antidote Treatment Nerve Agent Auto injector)
- Atropine (anticholinergic agent)
- Pralidoxime (reactivate cholinesterase)
CANA
(Convulsant Antidote for Nerve Agent)
Diazepam (benzodiazepine) to control nerve agent induced seizures
ALZHEIMERS DRUG LIST
Tacrine
Donepezil
Galantamine
Rivastigmine
Atropine
Anticholinergic (competitive)
MOA: Inhibits the muscarinic actions of acetylcholine (Central and Peripheral)
IND: EYE for Mydriasis/ Cycloplegic, Bradycardia, GI/GU antispasmodic (hypotonic radiography), Cholinergic OD
Route: PO, IV, IM, Eye ggts
MAKE SURE TO MONITOR PT ( HR, BP, AMS)
ADE: Blind, Mad, Red, Hot, Dry, Bowel Loose, Inc HR
Anti Cholinergics used in the eye
Atropine (we know this one)
Cyclopentolate
Tropicamide (we know this one)
MAO: produce mydriasis and cycloplegia, loss of accommodation
IND: Dx procedures, produces mydriasis and cycloplegia, eye exams
ADE: Photo sensitivity, inability to focus, anticholinergic affects ( Blind, Mad, Red, Hot, Bowel tone decreases, Tachycardia)
Anticholinergic for GU use
Oxybutyin Derifenacin Solifenacin Tolterodine Fesoterodine Trospium
MOA: Decreases bladder tone resulting in detrusor muscle relaxation and sphincter constriction
IND: overactive bladder
ADE: Dry mouth, constipation, anticholinergic effects
(Less ADE with a transdermal patch)
Anticholinergics used in GI
Dicyclomine
Belladonna Alkoloids
Dicyclomine
Anticholinergics for Gastrointestinal Use
MOA: Blocks Ach
IND: IBS
ADE: Anticholinergic effects, CNS defects, drowsiness, blurred vis. AMS, Psychosis/ delirium, Diarrhea
CAUTION: D/C Tx if diarrea occurs (sign of Incomplete obstruction)
Belladonna Alkaloids
Combination of Hyoscyamine, Atropine, Scopolamine, and Phenobarbital
Anticholinergics for Gastrointestinal Use
MOA: Inhibits Muscarinic reseptors
IND: IBS, acute enterocolitis, duodenal ulcer
ADE: Anticholinergic effects, CNS depression, Drowsiness, Psychosis/ delirium, Diarrhea
CAUTION: D/C Tx w/ Diarrhea, sign of incomplete obstruction
Anticholinergics used in the Lungs
Ipatropium (short acting)
Tiotropium ( long acting)
MOA: cholinergic antagonist that causes bronchodilation, decreases resp secretions
IND: COPD
ADE: Anticholinergic effects, (inhalation minimizes ADE)
(Less Efficacy in ASTHMA when compared to B2 agonists)
Should anticholinergics be used to treat acute asthma
No
Compared to β2 agonists, anticholinergics have similar or greater efficacy for COPD, but less efficacy for asthma
Anticholinergics are NOT appropriate for relief of acute asthma symptoms
Scopalamine
Belladonna Alkaloid
MOA: cholinergic antagonist with greater central than peripheral effects
IND: motion sickness, decreases saliva, blocks short term memory (surgical adjunct)
BE SURE TO MONITOR PT: HR, TEMP, UOP
ADE: Drymouth, drowsiness, Anticholinergic effects
CAUTION: Wash hands after handling the patch
Anticholinergics used for Parkinson’s
Benztropine (controls extrapyramidal d/o except dyskinesia)
Trihexyphenidyl
MOA: centrally-acting cholinergic antagonist in an attempt to restore its balance with dopamine levels
IND: Parkinson’s, adjunct with L-dopa and phenothiazines
ADE: anticholinergic effects
MOA of NMBA
Block acetycholine at the Nm (nicotinic muscle) at the neuromuscular junction at the skeletal muscle
Order of paralysis with NMBA
Order of paralysis (peripheral to central): face/eyes; fingers; limbs; neck; trunk muscles; intercostal muscles; diaphragm
Can cholinesterase inhibitors reverse depolroizing NMBA
Not in phase I, in phase II they potential can in late phase
Can AchE inhibitors reverse nondepolarizing NMBA
Yes, increasing Ach can compete with Nondepolaring NMBA as well as AchE inhibitors (Indirect Ach Agonists) such as neostigmine, pyridostigmine, and edrophonium
Succinylcholine
NMBA MOA: NMBA Depolarizing Agent IND: DOC from rapid sequence intubation, procedures lasting < 3min, Endoscopic exams, Convulsion therapy, Duration: 4-6 min DO NOT GIVE AS INFUSION MONITOR: Sedation, Temp, RR, K*
ADE: malignant hyperthermia, Apnea, HyperK*
Contra: Pmhx of Malignant Hyperthermia, muscle myopathies
Drug interactions: digoxin
Reversal agent for Malignant Hyperthermia
Dentrolene
What does atracurium metabolize to
Laudanosine ( can cross the BBB and cause SZR)
What is the NMBA DOC in renal and hepatic dz
Cisatracurium
OnabotulinumtoxinA
MOA: NMBA
Inhibits the release of acetylcholine from cholinergic nerve fibers at neuromuscular junctions
Produced by the bacteria clostridium botulinum
IND: Chronic Migraines ( 2nd line agent), Cervical Dystonia, Blepharospasm, Cosmetic Procedures : Glabellar lines, Rhytides, crows feet’s.
ADE: Double vision, blurred vision, eyelids droop, slurred speech, the head sags, the legs lose their ability to support one’s body, breathing stops, Pain at injection site
CAN BE A BIO WEAPON
What is the antidote for OnabotulinumtoxinA
Equine botulinum antitoxin
Brimonidine tartrate
Sympathetic agonist
MOA: decrease IOP, contracts radial muscle (mydriasis)
IND: OPEN ANGLE glaucoma or ocular HTN
Timolol
non-selective β-blocker B Antagonist MOA: decrease aqueos humor production With no effect on pupil IND: reduction of elevated IOP in OPEN ANGEL glaucoma or ocular HTN
Epi
Direct acting catecholamine
MOA: direct-acting catecholamine released by the adrenal medulla that is an agonist at both α and β receptors
(α1=α2; β1~β2)
Increase HR, CO, Inc SysBP, Bronchodialation, prolongs anesthetics.
IND: Bronchospasms, Anaphylaxis, Cardiac Arrest, Anesthetic adjunct.
ADE: Anxiety, tremor, HTN, Tachy HR, Cerebral Hemorrhage, Mydriasis, Hyperglycemia, Extravasation
What is the effect of EPI at low doses
< 0.5 mcg/kg/min
Vasodilation predominates (B2)
What is the effect of Epi at high doses
>0.5mcg/kg/min
Vasoconstriction predominates (a1)
What are the drug interactions of Epi
a- blockers, b-blockers, and increased the efficacy of MAOI and COMT inhibitors
Dipiverfin
MOA: prodrug metabolized to epinephrine in the eye that decreases IOP by contracting the radial muscle that opens the trabecular network to increase aqueous humor outflow
IND: OPEN ANGEL glaucoma
ADE: mydriasis, burning/ stinging
NE
Direct acting catecholamine
MOA: direct-acting catecholamine that is an agonist at both α and β receptors (α effects»_space; β1»_space;> β2)
Increases Vasoconstriction and inotropic effect.
SBP AND DBP
IND: short term treatment of shock, Arrhythmia
ADE: Anxiety, fear, tremor, HTN, Cerebral hemorrhagic 2/2 increased BP, extravasation
What the mortality difference when using dopamine or NE in Tx of shock
Dopamine»NE
No mortality difference
What are the drug interactions of NE
Same as EPI
a-blockers, b-blockers, increase efficacy of MOAI and COMT inhibitors
Isoproterenol
Direct acting catecholamine
MOA: Direct-acting catecholamine that is a non-selective agonist at β1 and β2 receptors (β1 = β2)
IND: bradyarrythmias, 3rd degree HB (temporary use)
MONITOR: EKG
ADE: Anxiety, fear, tremor, tachycardia, hyperglycemia
What are the drug interactions of Isoproterenol
COMT inhibitors may prolong action, b-blockers result in physiologic anatogonism
Dobutamine
Synthetic Direct Acting Catecholamine
MOA: synthetic, direct-acting catecholamine that is a selective β1 agonist
IND: increase CO in Acute decompensated HF
MONITOR: EKG
ADE: Headache, A fib
What are the drug interactions with dobutamine
COMT inhibitors may prolong action
b-blockers result in physiologic antagonism
Dopamine
Direct acting catecholamine
MAO: Direct-acting catecholamine that stimulates α, β, and dopamine (D) receptors, depending on dose
IND: Low dose: cardiac and septic shock, alternative to NE
MONITOR: EKG, VITAL SIGNS, UOP
ADE: Anxiety, tremor, tachy HR, HTN, Extravasation
Should low dose dopamine be used for renal protection
NO!
What are the drug interactions for Dopamine
A-blockers and b-blockers
Increase efficacy of MAOI and COMTI
What receprtors does Epi hit
A1 and 2 (more) ,
B1 and 2 (less)
What receptors does NE hit
A1 and 2 (more)
B1 and 2 (less)
What receptors does isoproterenol hit
Only B1 and B2
What receptors does dobutamine hit
A1 and 2 (less)
B1 (most)
B2 (less)
What receptors does dopamine hit
Dose dependent
Low dose B1 and D1
Medium dose B1, B2, D1 and minimal A1
High Dose A1, B1, B2, and no D1
Phenylephrine
Direct acting non-catecholamine
MOA: synthetic α1-agonist
Increases BP (SBP & DBP), dilates the pupil, constricts engorged ocular, nasal, and rectal vasculature to decrease redness and congestion, and shrinks hemorrhoids
IND: Tx of HOTN 2/2 Shock, Mydriasis for Eye exams, Relief of eye redness, hemorrhoids, and nasal decongestant.
MONITOR: BP (drug increases it)
ADE: Extravasation, HTN HA, Rebound Congestion
What are the drug interactions of phenylephrine
A-blockers and MAO-I
Oxymetazoline (AFRIN, Visine)
Direct acting non-catecholamine
MOA: Direct-acting α1 and α2 agonist
Eye drops or nasal spray produces vasoconstriction that decreases blood flow resulting in decreases ocular redness and nasal congestion
IND: Relief of red eye and congestion
ADE: rebound hyperemia and congestion, stinging/ burning sensation
Midodrine
Direct acting non catecholamine
MOA: Prodrug that forms an active metabolite, desglymidodrine, an α1 agonist
Causes vasoconstriction, increases SBP & DBP
IND: Orthostatic HOTN
ADE: HTN, Brady HR, Piloerection (GOOSEBUMPS), Paresthesia
What prodrug gets converted to desglymidodrine
Midodrine
What are the drug interactions for midodrine
MAO-I
Clonidine
Direct acting non catecholamine
MOA: Stimulates α2 presynaptic receptors in the brain stem (central)
Reduces sympathetic outflow from the CNS and decreases peripheral resistance, renal vascular resistances, heart rate, and blood pressure
IND: HTN, ADHD, (REMEMBER LUAREN SCHOOLED YOU), Tourette’s, Opiod WTDRWL, NICOTINE WTHDRWL
CAUTION: DO NOT D/C SUDDENLY
ADE: Drowsiness, Dizzy, Dry mouth, constipation, Itching, redness, Sodium and Water retention
What are the drug interactions of Clonidine
Enhances B-blockers (AV blocking effect)
Withdrawal b-blocker several days before clonidine withdrawal when possible (monitor BP closely)
Brimonidine
Direct acting non catecholamine
MOA: ocular α2-agonist, decreases aqueous humor production
IND: Glaucoma
ADE: burning/ stinging
b2 agonists
All end in -ol
MOA: β2 agonist that relaxes bronchial smooth muscle resulting in bronchodilation
IND: Asthma, COPD
MONITOR: Peak Expiratory Flow Rate (PEFR) and Pulmonary Function Tests (PFTs)
ADE: Increase BP, Tachy HR, Nervousness, restlessness, Hypo K*, hyperglycemia
What are the drug interactions of B2 agonists
B- blockers (primarily non selective)
What is the B agonist of choice for acute respiratory relief in COPD and asthma
Albuterol
What drug is a R-isomer of Albuterol
Levalbuterol
What B 2 agonist does not end in -ol and is used to suppress premature birth
Terbutaline
What is arformeterol only approved for
COPD
Is formoterol approved for acute relief of asthma
No, despite its rapid onset of action (less than 5 min)
What is Indacterol only approved for
COPD
Mirabegron
Direct acting non catecholamine
Mechanism of Action: β3 agonist that relaxes the detrusor muscle, increases bladder capacity
IND: Overactive bladder
ADE; increases BP
What are the drug interaction of Mirabegron
Anticholinergics for the bladder, (increases urinary retention)
Fenoldopam
Direct acting non catecholamine
MOA: D1 agonist that bind with moderate affinity to α2 receptors
Rapid acting vasodilator
Decreases peripheral vascular resistance and BP secondary to increased renal blood flow, and natriuresis/diuresis
IND: In hospital tax of severe HTN with renal compromise
-6x more potent as dopamine in producing renal vasodilation
ADE: HA, Flushing, Dizzyness, N/V, Reflex Tachy HR, Hypokalemia
What are the clinical uses of indirect acting adrenergic agonist
ADHD
Narcolepsy
Obesity
Depression
(METH, COCAINE)
What are the ADE of dextroamphetamine and methamphetamine
Insomnia, irritability, tremor, panic, SI, psychosis, dependency, HTN, palpitations, N/V/D, anorexia, stunted growth
Dextro- and methamphetamine are contraindicated in what pts..
Contraindicated in patients with hypertension, CV diseases, hyperthyroidism, and glaucoma
What are the drug interactions with Dextro- and methamphetamine
MAO-I
What are the drug interactions with tyramine
Like amphetamines, tyramine can enter nerve terminals and displace norepinephrine, which then acts on α-receptors.
Found in fermented foods.
Patients taking a mono amine oxidase inhibitors (MAOI) who eat tyramine containing foods can develop hypertensive crisis